| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the MDA/ALS Center, Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY.
Surgical procedures on the cervical spine are accepted therapies for the myelopathy of cervical spondylosis. However, reported improvement rates vary widely, and many reports indicate improvement in about onehalf of the cases. It has not been proven that outcome after surgery is better than the natural history or conservative therapy. Radiographic or imaging evidence of cord impingement or compression may be seen in asymptomatic people. There are no clear guides to the selection of patients who may benefit from the operation and there has been no standardization of preoperative evaluation, trials of conservative therapy, ascertainment of progressive disability, or assessment of outcome. A multicenter controlled trial might answer these questions.
Address correspondence and reprint requests to Dr. Lewis P. Rowland, MDA/ALS Center, Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY 10032–3784.
Supported by Center Grants from the National Institute of Neurological Diseases and Stroke (NS11766); GCRC-00645; and the Muscular Dystrophy Association.
Received May 20, 1991. Accepted for publication in final form June 20, 1991.
This article has been cited by other articles:
|
|
 |
|
  C. E Cook, E. Hegedus, R. Pietrobon, and A. Goode A Pragmatic Neurological Screen for Patients With Suspected Cord Compressive Myelopathy Physical Therapy, September 1, 2007; 87(9): 1233 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Tani, H Yamamoto, and J Kimura Cervical spondylotic myelopathy in elderly people: a high incidence of conduction block at C3-4 or C4-5 J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 456 - 464. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. A. Mueller, M. M. Moore, D.C.R. Kerr, G. Sexton, R. M. Camicioli, D. B. Howieson, J. F. Quinn, and J. A. Kaye Brain volume preserved in healthy elderly through the eleventh decade Neurology, December 1, 1998; 51(6): 1555 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr, R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, E. G. Tangalos, and E. Kokmen Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease Neurology, October 1, 1998; 51(4): 993 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Degenhardt, R. M. Duvoisin, J. Frennier, S. H. Gultekin, M. R. Rosenfeld, J. B. Posner, and J. Dalmau Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration Neurology, May 1, 1998; 50(5): 1392 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carpo, A. Cappellari, G. Mora, R. Pedotti, S. Barbieri, G. Scarlato, and E. Nobile-Orazio Deterioration of multifocal motor neuropathy after plasma exchange Neurology, May 1, 1998; 50(5): 1480 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.R.G. Guttmann, F. A. Jolesz, R. Kikinis, R. J. Killiany, M. B. Moss, T. Sandor, and M. S. Albert White matter changes with normal aging Neurology, April 1, 1998; 50(4): 972 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Lucchinetti, D. W. Kimmel, and V. A. Lennon Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies Neurology, March 1, 1998; 50(3): 652 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Mega, P. M. Thompson, J. L. Cummings, C. L. Back, M. L. Xu, S. Zohoori, A. Goldkorn, J. Moussai, L. Fairbanks, G. W. Small, et al. Sulcal variability in the Alzheimer's brain: Correlations with cognition Neurology, January 1, 1998; 50(1): 145 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Majamaa, J. Turkka, M. Karppa, S. Winqvist, and I. E. Hassinen The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct Neurology, November 1, 1997; 49(5): 1331 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr, R. C. Petersen, Y. C. Xu, S. C. Waring, P. C. O'Brien, E. G. Tangalos, G. E. Smith, R. J. Ivnik, and E. Kokmen Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease Neurology, September 1, 1997; 49(3): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abe, Y. Matsuo, J. Kadekawa, S. Inoue, and T. Yanagihara Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by noninvasive tissue oximetry Neurology, September 1, 1997; 49(3): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ellis, G. Lemmens, S.C. R. Williams, A. Simmons, J. Dawson, P. N. Leigh, and K. R. Chaudhuri Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study Neurology, August 1, 1997; 49(2): 438 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Sanders, P. Ian Andrews, J. F. Howard Jr., MD, and J. M. Massey Seronegative myasthenia gravis Neurology, April 1, 1997; 48(Suppl_5): 40S - 45S. [Full Text] [PDF]
|
|
|
|
|
|
R. E. Lovelace and D. S. Younger Myasthenia gravis with thymoma Neurology, April 1, 1997; 48(Suppl_5): 76S - 81S. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Ross, D. A. Yurgelun-Todd, P. F. Renshaw, L. C. Maas, J. H. Mendelson, N. K. Mello, B. M. Cohen, and J. M. Levin Age-related Reduction in Functional MRI Response to Photic Stimulation Neurology, January 1, 1997; 48(1): 173 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Adams, C. E. Jackson, R. A. Rauch, S. F. Hart, R. S. Kleinguenther, and R. J. Barohn Cervical Myelopathy With False Localizing Sensory Levels Arch Neurol, November 1, 1996; 53(11): 1155 - 1158. [Abstract] [PDF]
|
|
|
|
|
|
Assessment of plasmapheresis Neurology, September 1, 1996; 47(3): 840 - 843. [Full Text] [PDF]
|
|
|
|
|
|
V. Timmerman, P. De Jonghe, P. Spoelders, S. Simokovic, A. Lofgren, E. Nelis, J. Vance, J.-J. Martin, and C. Van Broeckhoven Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13 Neurology, May 1, 1996; 46(5): 1311 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Ahlskog, R. J. Uitti, P. A. Low, G. M. Tyce, J. F. O'Brien, and K. K. Nickander Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease Neurology, March 1, 1996; 46(3): 796 - 801. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Oh, G. Claussen, Z. Odabasi, and C. P. Palmer Multifocal demyelinating motor neuropathy: \\\ Neurology, October 1, 1995; 45(10): 1828 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.N. van Schaik, P.M.M. Bossuyt, A. Brand, and M. Vermeulen Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis Neurology, August 1, 1995; 45(8): 1570 - 1577. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
